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ABSTRACT
Objective: To examine whether the inverse association
between birth weight and blood pressure varies by skin
pigmentation and/or related genotypes.
Study design: 671 children from a predominantly
caucasian birth cohort were followed-up to adolescence
(mean (SD) age 14.4 (0.64)).
Methods: Data on birth weight, socioeconomic status,
maternal antenatal smoking, adolescent blood pressure
and polymorphisms of candidate genes were obtained
and analysed by multiple linear regression.
Results: An increase in birth weight of 1 kg was
associated with an non-significant difference in adoles-
cent systolic blood pressure of –0.53 mm Hg (95% CI –
1.72 to 0.66) per kg after adjustment for child age and
cohort entry criteria. The inverse association between
birth weight and systolic blood pressure was stronger for
those with darker skin (>2% melanin) (difference in
effect, p = 0.02), those with more copies of the C allele
of corticotropin-releasing hormone (CRH) +T1273C
(p = 0.06), and those with more copies of the short
( 236 bp) form of the 11b-HSD2{CA}nrepeat micro-
satellite (p = 0.03).
Conclusions: These findings add to the evidence that
cortisol-related pathways may account for at least part of
the observed birth weight–blood pressure associations.
An extensive body of research has shown that birth
weight is related to adverse outcomes such as
hypertension, risk of coronary heart disease and
type 2 diabetes, with smaller babies having greater
risk in later life.1 2 The underlying mechanisms are
still not clear, but genetic factors associated with
both fetal growth restriction and increased risk of
cardiovascular disease may be involved.3
There is currently considerable interest in this
link because of the rapidly increasing burden of
cardiovascular and metabolic disease in developing
countries, where low birth weight and growth
restriction of infants at birth are common. Further,
it is likely that the prevalence of the relevant
genotypes may vary by race. African–Americans,
Aborigines, Polynesians and people from the Indian
subcontinent have a higher risk of hypertension,
coronary heart disease and type 2 diabetes than
caucasians.4–7 Some of these higher-risk groups
have genotypes/phenotypes associated with long-
term adaptation to living in warm climates near
the equator, including an increase in skin pigmen-
tation. In evolutionary terms, it has been proposed
that famine may have forced selection for thrifty
fat-storing genes among generations.8 Similarly,
polymorphisms associated with retaining sodium,
such as the angiotensinogen gene (AGT) M235T
polymorphism, may have been beneficial for those
living in warmer climates.8 This evolutionary
perspective raises the question of whether genes
associated with darker skin pigmentation may
potentiate the association between low birth
weight and adverse cardiovascular outcomes, an
issue of public health significance.2 9 There is
conflicting evidence about the relative strength of
the association between birth weight and systolic
blood pressure (SBP) in black versus white children
or adults.10–13 These findings may be confounded by
sociocultural factors related to skin pigmentation
because people with different skin pigmentation
may live in different sociocultural conditions. No
study to date has examined the interaction
between measured skin pigmentation and birth
weight in relation to later sequelae in a relatively
homogeneous ethnic group where genetic associa-
tions can be examined free of cultural confounding.
Candidate genes that may modify the association
between low birth weight and blood pressure include
those that meet the following four criteria: (1) have
relevant biological functional effects; (2) are related
What this study adds
c The inverse birth weight–blood pressure
association varies by two cortisol-related genes,
CRH promoter and 11b-HSD2 genotype.
c The inverse birth weight–blood pressure
association also varies by skin pigmentation in a
caucasian population.
What is already known on this topic
c Low birth weight has been associated with
higher blood pressure in adult life.
c Glucocorticoids and the underlying
hypothalamic–pituitary–adrenal axis may
account for at least part of the observed birth
weight–blood pressure associations.
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to cardiovascular or metabolic outcomes; (3) are related to birth
size or modify the association between birth size and adverse
outcomes; (4) are related to skin pigmentation or differ across
racial groups with differing skin pigmentation. In this report, we
have focused on polymorphisms of the eight genes shown in
table 2. Detailed information is provided in the Appendix, but
genes that met our criteria were (i) angiotensin I-converting
enzyme (ACE),14–19 (ii) AGT,20–24 (iii) apolipoprotein E (APOE),25–27
(iv) paraoxonase 2 (PON2) polymorphism,28 29 (v) proinsulin
converting enzyme 1 (PC1),30–34 (vi) proopiomelanocortin
(POMC),35–37 (vii) 11b-hydroxysteroid dehydrogenase-2 (11b-
HSD2)38–41 and (viii) corticotropin-releasing hormone (CRH).42–47
The three cortisol-related genes (POMC, CRH, 11b-HSD2)
are of particular interest because there has been accumulating
evidence since the inception of this study that glucocorticoids
and the underlying hypothalamic–pituitary–adrenal (HPA) axis
may account for at least part of the observed birth weight–
blood pressure associations.48 49
We have previously reported an inverse association between
birth weight and childhood blood pressure in a follow-up of
predominantly caucasian infants.50 51 There are unlikely to be
major socioeconomic differences associated with skin pigmenta-
tion. We aimed to examine how the birth weight–blood
pressure association varied by skin pigmentation. Further, we
aimed to examine how the birth weight–blood pressure
association varied by selected genetic polymorphisms, particu-
larly those involved in cortisol-related pathways.
METHODS
Subjects
During the years 1988–1995, 10 569 children were recruited
soon after birth into the Tasmanian Infant Health Study, which
had been established to investigate sudden infant death
syndrome.52 The selection of eligible singleton subjects was
based on scores allocated for each of six risk factors for sudden
infant death syndrome (young maternal age, male infant, low
birth weight, month of birth, maternal intention to bottle feed,
and duration of the second stage of labour).52 Cohort eligibility
was automatic for multiple births. Of the 1498 eligible infants
born during 1988 or 1989 in southern Tasmania (a defined
geographical region), 1443 (96.3%) were recruited into the
Tasmanian Infant Health Study. They included 1283 singletons,
of whom 1028 were traced to the enrolment list of a school in
southern Tasmania in 1996 (1988 cohort) or 1997 (1989 birth
cohort), and 779 participated in follow-up studies during those
years.51 53 In 2002, 87.5% (682/779) of the participants in 1996–7
were retraced in adolescence to an address in southern
Tasmania, and 98.7% (673/682) of those retraced subsequently
participated in this further study. They represented 52.5% (673/
1283) of the total pool of eligible singletons in the 1988 and 1989
birth cohorts.
This study was approved by the Human Research Ethics
Committee (Tasmania), and parental written consent was
obtained.
Measurements
At birth or early infant life
Routinely collected obstetric data (gestational age in completed
weeks, placental weight, birth weight, crown-to-heel length,
head circumference) were extracted from the infant’s hospital
records at birth. Secondly, the study nurses administered a
questionnaire to their mothers in an in-hospital interview soon
after birth, and direct measurements of the infants were made
at that time.52
In childhood
Children who provided informed consent underwent measure-
ments of anthropometrics, blood pressure, blood chemistry and
lifestyle factors at follow-up in 1996 or 1997.51 53
In adolescence
Blood pressure was measured three times using a Critikon
Dinamap Adult/Pediatric Vital Signs Monitor or was deter-
mined elsewhere. Weight was measured without shoes or heavy
clothing using bathroom scales that were calibrated daily using
known weights. Skin reflectance was measured using a Minolta
spectrophotometer at the upper inner arm, a site exposed to
relatively little sun. The reflectance readings at wavelengths of
400 nm and 420 nm were used to calculate the percentage
concentration of cutaneous melanin at that site using the
method described in detail elsewhere.54
Genetic analyses
DNA collection
Duplicate buccal mucosa swabs were collected by brushing
inside the cheek with Gentra PureGene (Gentra Systems,
Minneapolis, MN, USA) collection brushes which were placed
in lysis solution immediately afterwards. In total, 671 samples
were collected, but DNA quality and quantity was not adequate
in some samples (table 2).
Genotyping
A conservative substitution in the CRH promoter at position
+1273 (CRH+T1273C) was detected as described by Gonzalez-
Gay et al.55 Single base substitutions (A to G in the PON2 gene
at codon 148 (PON2 Ala148Gly); C to T at codon 235 of the
AGT gene (AGT Met235Thr); A to C at codon 121 in plasma
cell membrane glycoprotein PC1 (PC1 Lys121Gln)) were
detected as described by Hegele et al,28 Russ et al56 and
Kubaszek et al,33 respectively. Two substitutions (C to T at
codon 112 and C to T at codon 158 in APOE (APOE Cys112Arg,
Cys158Arg)) were detected as described by Ossendorf and
Prellwitz.57 For the ACE gene, the insertion/deletion alleles
(ACE I/D) in intron 16 were detected as described by Chiu and
McCarthy.58 The POMC insertion/deletion alleles at exon 3
(POMC I/D), described by Morris et al,59 were amplified using a
Hex-labelled forward primer, POMCF 59-
AGTACGTCATGGGCCACTTC-39, and an unlabelled reverse
primer, POMCR 59-CATGGAGTAGGAGCGCTTG-39. Products
were then sized on an ABI PRISM 310 Genetic Analyser
Table 1 Characteristics of subjects at birth and at adolescent follow-up
in 2002–4
Males
(n = 470)
Females
(n = 203)
All subjects
(n = 673)
Birth weight in 1988 or 1989 (g)* 3338 (702) 2867 (757) 3204 (743)
Age in 2002–4 (years) 14.43 (0.65) 14.52 (0.62) 14.45 (0.64)
Cutaneous melanin in 2002–4 (%) 1.47 (1.53) 1.77 (1.51) 1.56 (1.53)
Systolic blood pressure in 2002–4
(mm Hg)
109.6 (10.7) 108.4 (10.5) 109.2 (10.7)
Diastolic blood pressure in 2002–4
(mm Hg)
55.7 (6.3) 58.0 (6.5) 56.4 (6.5)
Height in 2002–4 (cm) 166.8 (8.4) 159.6 (6.3) 164.4 (8.4)
Weight in 2002–4 (kg) 59.1 (14.0) 56.6 (11.4) 58.4 (13.3)
Values are mean (SD) (ie, sample mean (sample SD)).
*Birth weight (SD) for the entire eligible sample (n = 1443) was 3160 (798) for males
and 2769 (763) for females.
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(Applied Biosystems, Foster City, CA, USA). HSD2 CA repeat
alleles (11b-HSD2{CA}n) were amplified using a Fam-labelled
forward primer, HSDF 59-GTGTGCAAGATGTGGGTGAC-39,
and an unlabelled reverse primer, HSDR 59-
CCTGCTGAGGAGGGGTACTT-39. Reaction conditions and
sizing were the same as for POMC. The 11b-HSD2{CA}n
microsatellite varied from 230 bp to 248 bp and, by comparison,
corresponded to alleles 141–159 bp, as reported by Agarwal et
al,60 and with alleles 140–158 bp, as reported by Lavery et al.61 A
microsatellite with a low repeat number of 236 bp and below
was classified as short and denoted as 11b-HSD2{CA}n = short.
Reduced allelic repeat length has previously been associated
with reduced 11b-HSD2 activity.38
We provide the OMIM reference,62 reference NCBI database
SNP ID63 or GenBank accession code64 for the genetic
polymorphisms studied: (i) ACE, 106180, rs13447447; (ii)
AGT, 106150, rs699; (iii) APOE 107741, rs429358, rs7412; (iv)
PON2, 602447, rs12026; (v) PC1, 173335, rs1044498; (vi) POMC,
176830, rs10654394; (vii) 11b-HSD2, 218030, GenBank
AF071493; (viii) CRH, 122560, GenBank x67661.
Data analysis
Means and standard deviations of variables were calculated
from the original data or, where required, those data rescaled by
appropriate transformations. Melanin concentrations were
dichotomised at 2% for stratified analyses. This cut-off lies
near the median for caucasian adults.54 The strength of
associations between variables are summarised by correlation
coefficients and by linear regression coefficients. Linear trend
was assessed from the test of the regression coefficient of a
Table 2 Mean levels of birth weight, systolic blood pressure (SBP) and melanin density of adolescent
subjects classified by genotype
Genotype
No of
subjects
Birth weight
(g)
SBP
(mm Hg)
Cutaneous
melanin
(%)
Angiotensin 1-converting enzyme insertion/deletion (ACE I/D)
D/D 190 3203 (51) 110.8 (0.74) 1.48 (0.11)
I/D 308 3157 (40) 109.4 (0.57) 1.46 (0.09)
I/I 144 3269 (58) 109.7 (0.84) 1.66 (0.13)
Linear trend p = 0.47 p = 0.28 p = 0.31
Angiotensinogen Met235Thr (AGT Met235Thr)
Met/Met 158 3222 (55) 110.4 (0.80) 1.36 (0.13)
Met/Thr 200 3206 (49) 109.3 (0.71) 1.56 (0.11)
Thr/Thr 65 3222 (87) 108.2 (1.22) 1.67 (0.20)
Linear trend p = 0.94 p = 0.13 p = 0.14
Apoprotein E (ApoE)
e4/e4 18 3298 (165) 107.5 (2.3) 1.81 (0.37)
e4/e3 148 3084 (59) 109.5 (0.8) 1.39 (0.13)
e4/e2 16 3057 (181) 117.2 (2.7) 0.77 (0.37)
e3/e3 398 3215 (36) 109.8 (0.5) 1.61 (0.08)
e2/e2 or e2/e3 79 3334 (78) 109.6 (1.1) 1.46 (0.17)
e2/e2 4 2851 (374) 109.7 (5.0) 0.63 (0.73)
Difference of means p = 0.14 p = 0.11 p = 0.13
Paraoxonase 2 (Pon2 Ala148Gly)
Ala/Ala 365 3185 (38) 109.7 (0.5) 1.55 (0.08)
Ala/Gly 237 3183 (47) 110.5 (0.7) 1.46 (0.10)
Gly/Gly 53 3254 (98) 108.1 (1.4) 1.62 (0.22)
Linear trend p = 0.66 p = 0.76 p = 0.86
Plasma cell membrane glycoprotein-1 (PC1 Lys121Gln)
Ala/Ala 487 3228 (32) 109.8 (0.5) 1.52 (0.07)
Ala/Gly 167 3090 (56) 110.0 (0.8) 1.50 (0.12)
Gly/Gly 11 3145 (216) 109.0 (3.0) 1.55 (0.47)
Linear trend p = 0.04 p = 0.99 p = 0.91
Corticotropin-releasing hormone (CRH+T1273C)
T/T 527 3195 (31) 109.7 (0.4) 1.49 (0.06)
T/C 107 3169 (69) 110.9 (1.0) 1.55 (0.15)
C/C 10 3069 (229) 111.4 (3.3) 1.97 (0.51)
Linear trend p = 0.57 p = 0.23 p = 0.42
Proopiomelanocortin exon 3 insertion/deletion (POMC I/D)
D/D 597 3173 (29) 110.1 (0.4) 1.50 (0.06)
D/I 70 3342 (84) 107.6 (1.2) 1.67 (0.19)
I/I 3 2574 (449) 104.2 (5.5) 2.97 (0.95)
Linear trend p = 0.24 p = 0.03 p = 0.16
11b-Hydroxysteriod dehydrogenase CA repeat (11b-HSD2{CA}n)
238+/238+ 576 3187 (30) 109.9 (0.4) 1.52 (0.06)
238+/,238 76 3241 (82) 108.8 (1.2) 1.42 (0.18)
,238/,238 6 2756 (310) 120.0 (4.6) 2.69 (0.68)
Linear trend p = 0.88 p = 0.71 p = 0.67
Values are mean (SE) (ie, sample mean (estimated SE)).
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single predictor taking rank scores for ordered categories. In the
regression of outcome factors on genotype, a binary (0/1)
variable was used to represent each specific genotype other than
the most common (reference group) genotype, with trend
assessed using a single predictor coded for additive effects—that
is, taking consecutive integer scores for genotypes ordered in
decreasing frequency of the most common allele.
Regression models included terms for subject age at blood
pressure measurement and for cohort selection factors (mother’s
age, mother’s intention to breast feed, duration of second stage
labour, and child sex) to remove confounding that selection
based on these factors may have introduced. Birth weight,
another selection factor, was the main study factor and was
included in most analyses. Interaction between birth weight
and melanin density, between birth weight and genotype, and
between genotypes was assessed from the coefficient and
standard error of an interaction term formed from the
product of the relevant covariates.65 An extensive array of
questionnaire-based measures of parental, family and domestic
factors in infancy and childhood was available to control for
confounding by socioeconomic situation.
RESULTS
General characteristics
Table 1 shows subject characteristics. The median of the
measurements of cutaneous melanin was 1.5%, and the
interquartile range (25th to 75th centile) was 0.3–2.9%. The
highest melanin concentration recorded was 5.1%, and 94%
(627/667) of the sample had a value less than 4%, consistent
with a caucasian population. Similar proportions of boys (188/
470) and girls (82/202) had more than 2% melanin in their skin
(p = 0.95).
Birth weight, melanin density and SBP classified by genotype
Table 2 shows mean levels of birth weight and adolescent SBP
for each of the genotypes.
Inverse association between birth weight and SBP in
adolescence
In regression models with adjustment for age at examination
and cohort selection factors, birth weight was weakly inversely
associated with adolescent SBP. An increase in birth weight of
1 kg was associated with a change in SBP of –0.53 mm Hg (95%
CI –1.72 to 0.66, p = 0.33). After adjustment for current height
and weight, a 1 kg increase in birth weight was associated
(p,0.01) with a change in SBP of –1.87 mm Hg (95% CI–3.01
to –0.73). Associations were similar for boys and girls.
Stronger association of birth weight with SBP in those with
darker skin pigmentation
Darker skin pigmentation modified the association between
birth weight and adolescent SBP (interaction between birth
weight and increasing continuous melanin density, p = 0.03).
To best illustrate this interaction, we dichotomised the
continuous melanin measurements at 2%. For the 40% (267/
Figure 1 In the regression of adolescent systolic blood pressure (SBP)
on birth weight, independently estimated differences in SBP associated
with a 1 kg difference in birth weight for subjects classified by CRH and
11b-HSD2 genotype. The interactions between birth weight and the
genes expressed on a linear (additive) scale were significant for both
CRH (p = 0.04) and 11b-HSD2 (p = 0.01).
Table 3 Jointly estimated differences in systolic blood pressure (SBP) associated with a 1 kg difference in
birth weight in the regression of adolescent SBP on birth weight: analysis of interaction effects showing that
the change in SBP becomes more negative with darker skin type (>2% melanin), each additional copy of the
CRH+T1273C allele, and each additional copy of the shorter-sized 11b-HSD2{CA}n microsatellite
Predictor
Change in SBP (mm Hg)
Before further adjustment
Also adjusted for height and weight in
2002–4
b (95% CI)* p Value b (95% CI)* p Value
Birth weight{ 1.49 (–0.20 to 3.18) 0.08 –0.03 (–1.64 to 1.58) 0.18
Birth weight 6melanin skin type{ –2.71 (–4.91 to –0.51) 0.02 –2.64 (–4.70 to –0.57) 0.01
Birth weight 6 CRH+T1273C" –2.17 (–4.41 to 0.08) 0.06 –1.88 (–3.98 to 0.22) 0.08
Birth weight 6 11b-HSD2{CA}n1 –2.80 (–5.44 to –0.28) 0.03 –2.42 (–4.83 to –0.00) 0.05
*b (95% CI) = regression coefficient (95% confidence interval) adjusted for cohort selection factors other than birth weight, the age
of the subject in 2002–4, melanin skin type (>2%), C allele for CRH+T1273C and 11b-HSD2{CA}(236.
{Estimated difference in SBP per kilogram difference in birth weight for the reference group of subjects with ,2% cutaneous
melanin, T/T CRH+T1273C genotype and 238+/238+ 11b-HSD2{CA}n genotype.
{Estimated additional difference in SBP per kilogram difference in birth weight for subjects with >2% melanin.
"Estimated additional difference in SBP per kilogram difference in birth weight for each copy of the CRH+T1273C allele.
1Estimated additional difference in SBP per kilogram difference in birth weight for each copy of the shorter-sized 11b-HSD2{CA}n
microsatellite.
Original article
Arch Dis Child 2008;93:760–767. doi:10.1136/adc.2007.129122 763
 on 8 December 2008 adc.bmj.comDownloaded from 
667) of subjects with more than 2% melanin, an increase in
birth weight of 1 kg was associated with a more than 2 mm Hg
reduction in SBP (–2.12 mm Hg (95% CI –3.82 to–0.41). For the
remaining 60% (400/667) lighter-skinned subjects with less than
2% melanin, the association was weaker (0.42 mm Hg (95% CI
–1.05 to 1.89), and the greater magnitude of the birth weight–
SBP association in those with darker skin was significant
(difference in effect, p = 0.01).
Modification of the birth weight–SBP association by CRH and
11b-HSD2 genotype
With the genotypes expressed on a linear (additive) scale, we
found significant interactions between birth weight and these
two gene variants in the explanation of SBP: p = 0.04 for any C
allele for CRH+T1273C 6 birth weight and p = 0.01 for 11b-
HSD2{CA}n = short genotype 6birth weight (fig 1). For each of
these, the inverse association between birth weight and SBP was
strongest for subjects with two copies for the least common
alleles (fig 1).
Independent modification of the association between birth
weight and SBP by dark skin pigmentation or CRH and 11b-HSD2
genotype
Table 3 shows that the interaction between each of these three
factors and birth weight on adolescent SBP persisted when the
effects were considered in the same model. This indicates that
interaction between birth weight and each of these cortisol-
related genes or dark skin pigmentation could not be accounted
for by the other interactions. Further adjustment for adolescent
weight and height marginally reduced these interactions, with
the greatest change occurring in the estimated interaction
between birth weight and CRH+T1273C genotype (b=22.42,
p = 0.05 after adjustment).
Additional analyses
We conducted additional analyses to further investigate the
potential influence of gestation and socioeconomic confounding
on these main findings and we also examined gene epistasis.
Table 4 shows that the patterns observed for a stronger birth
weight–adolescent SBP association by darker skin, genotype or
11b-HSD2{CA}n = short genotype persisted after adjustment for
gestation. In addition, there was no evidence of interaction
between gestation length and darker skin (p = 0.17),
CRH+T1273C genotype (p = 0.87), or 11b-HSD2{CA}n = short
genotype (p = 0.45) with regard to adolescent SBP. Thus
gestation did not appear to explain the three interactions
observed in table 3.
Melanin density in this sample did not appear to be a marker
for socioeconomic status. Darker skin was weakly associated
with birth weight (r = –0.09, p = 0.02) and adolescent SBP (r = –
0.10, p = 0.01) but not with household income (r = 0.01,
p = 0.80), maternal education (r = –0.04, p = 0.27), the number
of persons sharing the household (r = –0.05, p = 0.27) or the
density of persons per room (r = –0.03, p = 0.49). Nor was it
associated with other recorded factors that have been linked to
lower socioeconomic status, namely private health insurance,
teenage motherhood or paternal unemployment (data not
shown.) Similarly, markers of lower socioeconomic status were
not associated with the CRH+T1273C variant or 11b-
HSD2{CA}n = short (data not shown). We further adjusted for
any maternal antenatal smoking, but this did not alter the
results in tables 3 and 4.
Because both CRH and 11b-HSD2 are part of signalling via
the HPA axis, we hypothesised that there may be gene–gene
interaction, but this was not evident (data not shown).
DISCUSSION
In this follow-up study, we tested the hypothesis that the
relationship between birth weight and adolescent SBP in a
caucasian sample differs by skin pigmentation and associated
candidate genotypes. We found that the relationship between
birth weight and adolescent blood pressure was modified by
three factors: greater skin pigmentation of the upper inner arm
(>2% melanin), the C allele of the CRH+T1273C allele, and
short allele of the 11b-HSD2{CA}n microsatellite.
Markers of lower socioeconomic status were not associated
with skin pigmentation or CRH+T1273C or 11b-HSD2{CA}n
Table 4 Estimated differences in systolic blood pressure (SBP) associated with a 1 kg difference in birth
weight for cutaneous melanin, CRH+T1273C or 11b-HSD2{CA}n genotype separately in the regression of
adolescent SBP on birth weight; effect of adjustment for gestational age
Subjects characterised by No*
Difference in SBP (mm Hg){
Before further
adjustment
Adjusted also for
gestational age
Cutaneous melanin
,2% melanin (lighter) 267 0.42 (–1.06 to 1.89) 1.31 (–0.44 to 3.05)
>2% melanin (darker) 400 –2.22 (–3.91 to –0.53) –1.18 (–3.20 to 0.83)
Interaction 667 –2.64 (–0.54 to –4.74) –2.49 (–4.59 to –0.39)
CRH+T1273C genotype
T/T 523 –0.02 (–1.40 to 1.39) 0.78 (–0.94 to 2.50)
T/C 106 –2.62 (–5.31 to 0.06) –1.77 (–4.44 to 0.89)
C/C 9 –3.82 (–11.22 to 3.59) –2.30 (–9.95 to 5.36)
Interaction 638 –2.29 (–4.53 to –0.04) –2.13 (–4.38 to 0.12)
11b-HSD2{CA}n genotype
238+/238+ 570 –0.24 (–1.53 to 1.04) 0.84 (–0.83 to 2.52)
238+/,238 76 –1.04 (–3.94 to 1.85) –0.29 (–3.27 to 2.70)
,238/,238 6 –11.19 (–20.41 to –1.97) –9.82 (–19.11 to –0.52)
Interaction 652 –3.08 (–5.61 to –0.56) –3.29 (–5.82 to –0.77)
*Number of subjects, which may differ slightly from those given elsewhere because of missing data on one or more of the
adjustment factors.
{b (95% CI) = regression coefficient (95% confidence interval) adjusted for cohort selection factors other than birth weight, and
for the age of the subject in 2002–4.
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genotype, reducing the likelihood that these factors were
markers of an adverse sociocultural environment that, in itself,
may contribute to the birth weight–blood pressure association.
Similarly, maternal antenatal smoking was not associated with
these three characteristics, and adjustment for antenatal
smoking did not alter the study findings in tables 3 and 4.
Further, as shown by the lack of association of these genes with
melanin concentration, CRH+T1273C and 11b-HSD2{CA}n
genotype did not appear to be antecedents of skin pigmentation
in this caucasian sample. The lack of association of ACE I/D and
AGT Met235Thr with blood pressure is surprising, and suggests
that the influence of these genes on blood pressure is via a
pathway that is not associated with skin pigmentation.
The strengths of this study were: the sample was drawn from
a relatively homogeneous caucasian population, reducing
problems related to population stratification; the range of study
measurements was comprehensive; the design was prospective.
Because adjustment for adolescent weight may be inappropriate
when studying the effect of birth weight on later outcomes if
the putative effect is mediated by child growth or weight,66
results were provided without adjustment for child size, and
further results with adjustment for adolescent height and
weight were supplied as supplementary analyses.
Limitations of this study include the inability to assess the
influence of darker skin pigmentation across a wider range of
skin types, thus these results cannot be extrapolated beyond a
caucasian population. Further, owing to the sample size and
predominance of males and the analytical aim of assessing
interactions, we were not able to examine in detail sex-specific
effects, which may be important. However, no differences in
the birth weight–blood pressure association were observed
between females and males.
The findings in relation to CRH+T1273C and 11b-
HSD2{CA}n genotype add to the growing evidence that
glucocorticoids, mineralocorticoids and the underlying HPA
axis may account for at least part of the observed birth weight–
blood pressure associations.48 67
Fetal exposure to cortisol is thought to reset the developing
HPA axis, leading to raised cortisol in the offspring.67 Growth-
restricted infants have higher cord blood cortisol,68 with
increased HPA activity found in adulthood.49 In Jamaican
children, a strong dose–response between fasting plasma
cortisol and SBP at age 8–9 has been reported.48 Little work
has been published on the effect of T to C polymorphism in the
CRH promoter, and it has only recently been established that
CRH reactivity varies between the promoter alleles.42 However,
a possible link to dysregulated HPA activity exists.44 11b-
HSD2{CA}n genotype is linked to increased cortisol signalling
in mineralocorticoid-sensitive tissues.38 Given that both CRH
and 11b-HSD2 genes are involved in cortisol-related pathways,
we assessed epistasis between the two gene variants, but gene–
gene interaction was not evident. Increasing the likelihood that
the cortisol-related pathways are important, a third gene
polymorphism, the I allele of POMC, was associated with
lower blood pressure (table 2), consistent with the known
effects of the POMC I form being associated with reduced
adrenocorticotrophin-related hypertension.69
Our findings suggest that the inverse association between
birth weight and adolescent SBP varies by genotype. In
particular, genes pertaining to cortisol-related pathways and
skin pigmentation appeared important in this caucasian
adolescent population. A strength of this study was that we
had available a range of markers of socioeconomic status with
which to evaluate potential sociocultural confounding, but a
limitation is that non-caucasian populations were not studied.
The findings have added to other evidence that cortisol-related
pathways may at least partly underlie the inverse association
between size at birth and later blood pressure.
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APPENDIX
Table AI Selected gene variants of interest in relation to skin pigmentation, birth weight and blood pressure
Gene (OMIM* reference)
ACE Chr17q23
(106180)
AGT Chr1q42-
q43 (106150)
ApoE Chr 19q13.3
(107741)
PON2 Chr 7q21.3
(602447)
PC1 Chr
6q22q-23
(173335)
POMC Chr 2p23.3
(176830)
11b-HSD2 Chr
16q22 (218030)
CRH Chr 8q13
(122560)
Name of
measured
polymorphism
ACE I/D, 288 bp
insertion (I)/
deletion (D) in
intron 16
AGT Met235Thr APOE e2, e3, or e4
e2 = 112Cys/
158Cys
e3 = 112Cys/
158Arg
e4 = 112Arg/
158Arg
PON2 Ala148Gly PC1
Lys121Gln
POMC I/D, 9 bp
insertion (I) or
deletion (D) in
exon 3
11b-HSD2{CA}n
repeat with short
alleles (236 bp
CRH+T1273C in
59UTR promoter
(Reference NCBI
database SNP ID
or GenBank
Accession Code)
(rs13447447) (rs699) Cys112Arg
(rs429358)
Arg158Cys
(rs7412)
(rs12026) (rs1044498) (rs10654394) (GenBank
AF071493)
(GenBank
x67661)
Functional effect
of genetic variant
Circulating ACE
levels highest in
ACE D/D
subjects, twice
that of ACE I/I and
intermediate in
ACE I/D14 15
Met235Thr
changes AGT
gene expression
and linked
hypertension in
some
populations.
Thr235Thr is the
ancestral form,
advantageous in
salt scarcity20
APOE variants
influence the
efficiency and type
of lipoprotein
carriage. The most
common (wild-
type) = e3/e33,
with e4 allele
associated with
higher serum
cholesterol25
PON2 hydrolyses
the products of
LDL oxidation,
related to HDL-
associated
cardioprotection.
Gly148Gly
associated with
higher mean
fasting plasma
glucose28
Allelic variants
change insulin
signalling at
the site of the
insulin
receptor.
Variants that
upregulate
PC1 inhibit
insulin
receptor
activity30
POMC gene
inactivation is
associated with
reduced ACTH and
MSH production.
The exon 3
insertion is
associated with a
loss of POMC
function with I/D
having 24% higher
insulin than D/D
and also lower
insulin sensitivity35
The 11b-HSD2
gene controls
enzyme activity for
the breakdown of
cortisol and related
products. Defects
in function result in
higher circulating
glucocorticoids.
Short alleles are
associated with
fewer CA(n)
repeats and
reduced enzyme
activity38
It has only
recently been
established that
CRH reactivity
varies between
promoter alleles.42
Psychotropics
can inhibit the
CRH gene,43 44 so
a possible link to
dysregulated HPA
activity exists
Association
between genetic
variant and
disease
I/D q insulin
resistance, q
cardiovascular
disease risk,
especially in
those with
diabetes16 17
Thr235Thr is
related to salt-
sensitive
hypertension21
e4 allele is
associated with
adverse
dyslipidaemia,
particularly if e4/e4
(familial
dyslipidaemia type
V)26
Various PON2
variants are
associated with
CHD risk,
Gly148Gly alleles
associated with
higher plasma
glucose levels
among diabetics28
121Gln Variant
associated
with altered
insulin and
plasma
glucose after
oral glucose
test.31
121Gln Variant
associated
with primary
insulin
resistance in
Indians and
childhood
obesity32
POMC inactivation
is associated with
early onset obesity,
adrenal
insufficiency and
altered
pigmentation36
Essential
hypertension39 and
salt-sensitive
hypertension40
associated with
reduced 11b-HSD2
activity
HPA activation by
CRH is implicated
in stress-induced
hypertension and
cortisol-related
hypertension45
Association
between genetic
variant and
perinatal factors
In low birth
weight, ACE I
Rq adult insulin
secretion18
Thr235 allele
associated with
plasma
triglycerides in
neonates in
Trinidad22
Effect of APOE
genotype on LDL
levels was found to
be greater in low-
birthweight
babies25
Ala148Ala
genotype
associated with
low birth weight
in South Asians29
In a Finnish
birth cohort,
121Gln allele
was
associated
with type 2
diabetes in
babies of low
length
(,49 cm) but
not among
longer
infants33
Reduced 11b-HSD2
is associated with
low birth weight
and hypertension41
Positive correlation
between placental
HSD11B2 activity
and birth weight41
High CRH levels
at 26 weeks’
gestation are
associated with
subsequent
preterm delivery46
Association
between genetic
variant and race
or skin
pigmentation
Conflicting
results. ACE D
allele over-
represented in
Afro-Caribbean
compared with
caucasians19
Thr235 allele
more common in
dark skin
races.23 20 M more
common in white
than Japanese24
e4 allele is
associated with a
‘‘thrifty’’ genotype
re food scarcity. In
Europeans, more
common for higher
latitude27
Not reported 121Gln variant
higher in
Asians than
caucasians.
Prevalence
also high in
Dominican
republic34
POMC loss-of-
function mutations
result in a loss of
pigmentation37
Skin
melanogenesis,
stimulated by
glucocorticoids,
could be affected
by 11b-HSD2
activity because of
the build up of
cortisol
C gene is
ancestral form,
with T gene
having a higher
prevalence in
caucasians(0.9)
than Africans
(0.3)47
ACTH, adrenocorticotrophin; CHD, coronary heart disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MSH, melanocyte stimulating hormone.
Original article
Arch Dis Child 2008;93:760–767. doi:10.1136/adc.2007.129122 767
 on 8 December 2008 adc.bmj.comDownloaded from 
